HCWB Earnings

Quarterly EPS
$-24.78
Q3 2024
$-6.98
Q4 2024
$-11.82
Q1 2025
$-40.72
Q2 2025
$-12.12
Q3 2025
$-4.41
Q4 2025
$2.22
Q1 2026
$-11.58
Q2 2026
Latest Revenue135.6K
Latest Net Income-5219231
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$11.58135.6K-5219231+1,969.7%+71.6%
Q1 2026$2.226.5M3.5M+129,080.7%+118.8%
Q4 2025-$4.4127.0K719.2K-93.2%+36.8%
Q3 2025-$12.1215.6K-4554336-96.3%+51.1%
Q2 2025-$40.726.5K-1927730-98.9%+58.0%
Q1 2025-$11.825.1K-2196875-99.6%-885.0%
Q4 2024-$6.98394.8K-3373273-70.2%+90.2%
Q3 2024-$24.78426.4K-3902288-50.0%+26.3%
Q2 2024-$96.96618.9K-15280191
Q1 2024-$1.201.1M-7468061
Q4 2023-$71.211.3M-10680531
Q3 2023-$33.60853.1K-4938641
HCW Biologics (HCWB) — Earnings